Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL756834 | 0.75 | TSHR (0.35) | CA12CA1CA2CA9 | |
| Hydrogen Sulfide SCHEMBL28249500 | 0.73 | TSHR (0.34) | CA12CA1CA2CA9 | |
| SCHEMBL7207231 | 0.73 | — | — | |
| Fluoride SCHEMBL28144875 | 0.73 | TSHR (0.34) | CA12CA1CA2CA9 | |
| SCHEMBL28316984 | 0.73 | — | — | |
| SCHEMBL6280586 | 0.71 | FAAH (0.40) | CA2 | |
| SCHEMBL175854 | 0.71 | — | — | |
| SCHEMBL253162 | 0.71 | — | — | |
| SCHEMBL6310315 | 0.69 | — | — | |
| SCHEMBL756566 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107275722-A | Battery or fuel cell system | 辉光能源公司 | 2017-10-20 | — | — | CN | disclosed |
| US-8859590-B2 | Inhibitors of BACE1 and methods for treating Alzheimer's disease | PURDUE RESEARCH FOUNDATION (US) | 2014-10-14 | — | — | US | disclosed |
| CN-102549836-A | Heterogeneous hydrogen-catalyst power system | BLACKLIGHT POWER INC | 2012-07-04 | — | — | CN | disclosed |
| US-20110275619-A1 | INHIBITORS OF BACE1 AND METHODS FOR TREATING ALZHEIMER'S DISEASE | PURDUE RESEARCH FOUNDATION (US) | 2011-11-10 | — | — | US | disclosed |
| US-20050159431-A1 | Substituted alkyl uracils and thereof | BAYER HEALTHCARE AG (DE) | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275619-A1 | INHIBITORS OF BACE1 AND METHODS FOR TREATING ALZHEIMER'S DISEASE | BACE1, BACE2, PSEN2 | CA12 2907/4885CA1 292/4885CA2 2513/4885 |
| US-20050159431-A1 | Substituted alkyl uracils and thereof | UNG, UMPS, TYMP | CA12 4709/4885CA1 4698/4885CA2 4876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.